-
NEW TREATMENT EVIDENCE FOR THE MOST SEVERE STROKES
Written by JNF Medical Advisory Board Member – Dr. Michael Chen of Rush University More common than ruptured brain aneurysms, and still involving brain blood vessels, is ischemic stroke. A blockage of a major blood vessel in the brain can cause a range of neurological problems and disabilities depending on what part of the brain is […]
Posted on Sunday, March 15, 2015Read More -
GROUNDBREAKING STUDIES FIND THAT NEUROINTERVENTIONAL SURGERY REDUCES STROKE MORTALITY
WASHINGTON, DC – February 11, 2015 – Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities. The ESCAPE study, published today in the New England Journal of Medicine, also shows that […]
Posted on Friday, February 13, 2015Read More -
Best Friends Together Again
Today, the world lost a wonderful man and heaven gained a true angel. Dave Bergman, former Chairman of the Board of The Joe Niekro Foundation and best friend of the late Joe Niekro, passed away this morning after a fearlessness battle with cancer. There aren’t words to describe what this man meant to the entire Niekro family […]
Posted on Tuesday, February 3, 2015Read More -
JNF Awards $90,000 in Research Grants
The Joe Niekro Foundation has announced the 2014 Joe Niekro Research Grant recipients. A total of $90,000 has been awarded by the foundation, which is committed to supporting patients and families, research, treatment and awareness of brain aneurysms, AVMs and hemorrhagic strokes. “We are thrilled to award these recipients with this critical funding needed to […]
Posted on Monday, January 19, 2015Read More -
Groundbreaking Study Confirms That Neurointerventional Surgery Provides Significant Clinical Benefit
Study is most significant stroke treatment clinical trial since NINDS-2 says Society of NeuroInterventional Surgery WASHINGTON, DC – December 17, 2014 – A new study published in the New England Journal of Medicine confirms that the addition of inside-the-artery clot removal is more effective than IV-administered “clot-busting” tissue plasminogen activator (IV-tPA) therapy alone for the […]
Posted on Wednesday, December 17, 2014Read More